← Back to Search

AI Algorithm for Identifying Palliative Care Needs in Ovarian Cancer

N/A
Recruiting
Led By Rachel D. Havyer, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult patient in Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) with a diagnosis of advanced gynecologic malignancy (International Classification of Diseases [ICD] codes C51 through C58)
Be older than 18 years old
Must not have
Patients under the age of 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a computer program called artificial intelligence (AI) to see if it can identify patients with gynecologic cancer that has spread and who may benefit from palliative care. Palliative care

Who is the study for?
This trial is for patients with advanced gynecologic cancer, such as genital warts or ovarian cancer. It's designed to see if an AI algorithm can identify those who would benefit from outpatient palliative care to manage symptoms and improve quality of life.
What is being tested?
The study tests an AI algorithm that reviews electronic health records to pinpoint patients needing palliative care consultations. The goal is to reduce delays in referrals and ensure care aligns with patient goals.
What are the potential side effects?
Since this trial involves a non-invasive review of medical records using an internet-based intervention, there are no direct physical side effects associated with the AI algorithm being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have an advanced gynecologic cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Timely identification for need of palliative care
Secondary study objectives
Number of advanced care planning notes documented in the electronic health record
Number of billing codes International Classification of Diseases, 10th Revision for palliative care
Number of palliative care consultations
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (AI algorithm)Experimental Treatment2 Interventions
Patients' medical records are reviewed for consideration of palliative care consult using AI algorithm QW for 6 months.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,333 Previous Clinical Trials
3,059,775 Total Patients Enrolled
10 Trials studying Ovarian Cancer
3,508 Patients Enrolled for Ovarian Cancer
Rachel D. Havyer, M.D.Principal InvestigatorMayo Clinic in Rochester
~248 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top